ReviewHematology reports2024

A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia.

Anna Candoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.